1. Warmbrand M. How Thousands of My Arthritis Patients Regained Their
Health. New York: Arco Publishing, 1974. 2. Childers NF. A relationship of arthritis to the solanaceae
(nightshades). J Internat Acad Pre Med 1982;Nov:31–7. 3. Childers NF, Margoles MS. An apparent relation of nightshades
(Solanaceae) to arthritis. J Neurol Orthop Med Surg 1993;14:227–31. 4. Taylor MR. Food allergy as an etiological factor in arthropathies: a
survey. J Internat Acad Prev Med 1983;8:28–38 [review]. 5. Felson DT, Zhang Y, Anthony JM, et al. Weight loss reduces the risk
for symptomatic knee osteoarthritis in women. The Framingham Study. Ann Intern Med
1992;116:535–9. 6. Felson DT, Zhang Y, HanNan MT, et al. Risk factors for incident
radiographic knee osteoarthritis in the elderly: the Framingham Study. Arthritis
Rheum 1997;40:728–33. 7. Altman RD, Lozada CJ. Practice guidelines in the management of
osteoarthritis. Osteoarthritis Cartilage 1998;6(Suppl A):22–4 [review]. 8. Tapadinhas MJ, Rivera IC, Bignamini AA. Oral glucosamine sulphate in
the management of arthrosis: report on a multi-centre open investigation in Portugal.
Pharmtherapeutica 1982;3:157–68. 9. Giordano N, Nardi P, Senesi M, et al. The efficacy and safety of
glucosamine sulfate in the treatment of gonarthritis. Clin Ter
1996;147:99–105. 10. D’Ambrosio E, Casa B, Bompani G, et al. Glucosamine sulphate: a
controlled clinical investigation in arthrosis. Pharmatherapeutica
1981;2(8):5048. 11. Crolle G, DiEste E. Glucosamine sulfate for the management of
arthrosis. Curr Ther Res 1980;7:104–9. 12. Qiu GX, Gao SN, Giacovelli G, et al. Efficacy and safety of
glucosamine sulfate versus ibuprofen in patients with knee osteoarthritis.
Arzneimittelforschung 1998;48:469–74. 13. Reichelt A, Förster KK, Fischer M, et al. Efficacy and safety of
intramuscular glucosamine sulfate in osteoarthritis of the knee.
Arzneimittelforschung 1994;44:75–80. 14. Drovanti A, Bignamini AA, Rovati AL. Therapeutic activity of oral
glucosamine sulfate in osteoarthritis: a placebocontrolled doubleblind
investigation. Clin Ther 1980;3(4):260–72. 15. Vaz AL. Double-blind clinical evaluation of the relative efficacy of
ibuprofen and glucosamine sulphate in the management of osteoarthritis of the knee in
outpatients. Curr Med Res Opin 1982;8(3):145–9. 16. Pujalte JM, Llavore EP, Ylescupidez FR. Double-blind clinical
evaluation of oral glucosamine sulphate in the basic treatment of osteoarthrosis. Curr Med
Res Opin 1980;7(2):110–4. 17. Rindone RP. Randomized controlled trial of glucosamine for treating
osteoarthritis of the knee. West J Med 2000;172:91–4. 18. Reginster JY, Deroisy R, Rovati L, et al. Long-term effects of
glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical
trial. Lancet 2001;357:251–6. 19. Houpt JB, McMillan R, Wein C, Paget-Dellio SD. Effect of glucosamine
hydrochloride in the treatment of pain of osteoarthritis of the knee. J Rheumatol
1999;26:2423–30. 20. Kerzberg EM, Roldan EJA, Castelli G, Huberman ED. Combination of
glycosaminoglycans and acetylsalicylic acid in knee osteoarthritis. Scand J Rheum
1987;16:377. 21. Baici A, Hörler D, Moser B, et al. Analysis of
glycosaminoglycans in human serum after oral administration of chondroitin sulfate.
Rheumatol Int 1992;12:81–8. 22. Kerzberg EM, Roldán EJA, Castelli G, Huberman ED. Combination of
glycosaminoglycans and acetylsalicylic acid in knee osteoarthrosis. Scand J Rheumatol
1987;16:377–80. 23. Rovetta G. Galactosaminoglycuronoglycan sulfate (Matrix) in therapy
of tibiofibular osteoarhtirits of the knee. Drugs Exptl Clin Res
1991;17:53–7. 24. Conte A, Volpi N, Palmieri L, et al. Biochemical and pharmacokinetic
aspects of oral treatment with chondroitin sulfate. Arzneimittelforschung
1995;45:918–25. 25. Ronca F, Palmieri L, Panicucci P, Ronca G. Anti-inflammatory active
of chondroitin sulfate. Osteoarthritis Cartilage 1998;6(Suppl A):14–21. 26. Uebelhart D, Thonar EJ, Delmas PD, et al. Effects of oral chondroitin
sulfate on the progression of knee osteoarthritis: a pilot study. Osteoarthritis
Cartilage 1998;6(Suppl A):39–46. 27. Verbruggen G, Goemaere S, Veys EM. Chondroitin sulfate: S/DMOAD
(structure/disease modifying anti-osteoarthritis drug) in the treatment of finger joint OA.
Osteoarthritis Cartilage 1998;6(Suppl A):37–8. 28. Bucsi L, Poór G. Efficacy and tolerability of oral chondroitin
sulfate as a symptomatic slow-acting drug for osteoarthritis (SYSADOA) in the treatment of
knee osteoarthritis. Osteoarthritis Cartilage 1998;6(Suppl A):31–6. 29. Bourgeois P, Chales G, Dehais J, et al. Efficacy and tolerability of
chondroitin sulfate 1200 mg/day vs chondroitin sulfate 3X400 mg/day vs placebo.
Osteoarthritis Cartilage 1998;6(Suppl A):25–30. 30. Pipitone V, Ambanelli U, Cervini C, et al. A multicenter,
triple-blind study to evaluate galactosaminoglucuronoglycan sulfate versus placebo in patients
with femorotibial gonarthritis. Curr Ther Res 1992;52:608–38. 31. Bazières B, Loyau G, Menkès CJ, et al. Le chondroïtine
sulfate dans le traitement de la gonarthrose et de la coxarthrose. Rev Rhum Mal
Ostéoartic 1992;59:466–72 [in French]. 32. Conrozier T, Vignon E. Die Wirkung von Chondroitinsulfat bei der
Behandlung der Hüft Gelenksarthrose. Eine Doppelblindstudie gegen Placebo. Litera
Rheumatologica 1992;14:69–75 [in German]. 33. L’Hirondel JL. Klinische Doppelblind-Studie mit oral
verabreichtem Chondroitinsulfat gegen Placebo bei der tibiofermoralen Gonarthrose (125
Patienten). Litera Rheumatologica 1992;14:77–82 [in German]. 34. Morreale P, Manopulo R, Galati M, et al. Comparison of the
antiinflammatory efficacy of chondroitin sulfate and diclofenac sodium in patients with knee
osteoarthritis. J Rheumatol 1996;23:1385–91. 35. Leeb BF, Petera P, Neumann K. Results of a multicenter study of
chondroitin sulfate (Condrosulf) use in arthroses of the finger, knee and hip joints. Wien
Med Wochenschr 1996;146:609–14. 36. Bourgeois P, Chales G, Dehais J, et al. Efficacy and tolerability of
chondroitin sulfate 1200 mg/day vs chondroitin sulfate 3X400 mg/day vs placebo.
Osteoarthritis Cartilage 1998;6(Suppl A):25–30. 37. Schumacher HR. Osteoarthritis: the clinical picture, pathogenesis,
and management with studies on a new therapeutic agent, S-adenosylmethionine. Am J
Med 1987;83(Suppl 5A):1–4 [review]. 38. Harmand MF, Vilamitjana J, Maloche E, et al. Effects of
S-adenosylmethionine on human articular chondrocyte differentiation: an in vitro study. Am
J Med 1987;83(Suppl 5A):48–54. 39. Berger R, Nowak H. A new medical approach to the treatment of
osteoarthritis. Report of an open phase IV study with ademetionine (Gumbaral). Am J
Med 1987;83:84–8. 40. Domljan Z, Vrhovac B, Durrigl T, Pucar I. A double-blind trial of
ademetionine vs naproxen in activated gonarthrosis. Int J Clin Pharmacol Ther Toxicol
1989;27:329–33. 41. Müller-Fassbender H. Double-blind clinical trial of
S-adenosylmethionine in versus ibuprofen in the treatment of osteoarthritis. Am J Med
1987;83(Suppl 5A):81–3. 42. Vetter G. Double-blind comparative clinical trial with
S-adenosylmethionine and indomethacin in the treatment of osteoarthritis. Am J Med
1987;83(Suppl 5A):78–80. 43. Maccagno A. Double-blind controlled clinical trial of oral
S-adenosylmethionine versus piroxicam in knee osteoarthritis. Am J Med 1987;83(Suppl
5A):72–7. 44. Caruso I, Pietrogrande V. Italian double-blind multicenter study
comparing S-adenosylmethionine, naproxen, and placebo in the treatment of degenerative joint
disease. Am J Med 1987;83(Suppl 5A):66–71. 45. Marcolongo R, Giordano N, Colombo B, et al. Double-blind multicentre
study of the activity of s-adenosyl-methionine in hip and knee osteoarthritis. Curr Ther
Res 1985;37:82–94. 46. Glorioso S, Todesco S, Mazzi A, et al. Double-blind multicentre study
of the activity of S-adenosylmethionine in hip and knee osteoarthritis. Int J Clin
Pharmacol Res 1985;5:39–49. 47. Montrone F, Fumagalli M, Sarzi-Puttini P, et al. Double-blind study
of S-adenosyl-methionine versus placebo in hip and knee arthrosis. Clin Rheumatol
1985;4:484–5. 48. Konig B. A long-term (two years) clinical trial with
S-adenosylmethionine for the treatment of osteoarthritis. Am J Med
1987;83:89–94. 49. Bradley JD, Flusser D, Katz BP, et al. A randomized, double blind,
placebo controlled trial of intravenous loading with S-adenosylmethionine (SAM) followed by or
SAM therapy in patients with knee osteoarthritis. J Rheumatol
1994;21:905–11. 50. Di Padova C. S-adenosylmethionine in the treatment of osteoarthritis.
Review of the clinical studies. Am J Med 1987;83:60–5 [review]. 51. McAlindon TE, Jacques P, Zhang Y. Do antioxidant micronutrients
protect against the development and progression of knee osteoarthritis? Arthrit Rheum
1996;39:648–56. 52. Machtey I, Ouaknine L. Tocopherol in osteoarthritis: a controlled
pilot study. J Am Geriatr Soc 1978;25(7):328–30. 53. Blankenhorn G. Klinische Wirtsamkeit von Spondyvit (vitamin E) bei
aktiverten arthronsen. Z Orthop 1986;124:340–3 [in German]. 54. Scherak O, Kolarz G, Schödl Ch, Blankenhorn G. Hochdosierte
Vitamin-E-Therapie bei Patienten mit aktivierter Arthrose. Z Rheumatol
1990;49:369–73 [in German]. 55. Brand C, Snaddon J, Bailey M, Cicuttini F. Vitamin E is ineffective
for symptomatic relief of knee osteoarthritis: a six month double blind, randomised, placebo
controlled study. Ann Rheum Dis 2001;60:946–9. 56. Kaufman W. The use of vitamin therapy for joint mobility. Therapeutic
reversal of a common clinical manifestation of the ‘normal’ aging process.
Conn State Med J 1953;17(7):584–9. 57. Kaufman W. The use of vitamin therapy to reverse certain concomitants
of aging. J Am Geriatr Soc 1955;11:927. 58. Hoffer A. Treatment of arthritis by nicotinic acid and nicotinamide.
Can Med Assoc J 1959;81:235–8. 59. Jonas WB, Rapoza CP, Blair WF. The effect of niacinamide on
osteoarthritis: a pilot study. Inflamm Res 1996;45:330–4. 60. Gibson SL, Gibson RG. The treatment of arthritis with a lipid extract
of Perna canaliculus: a randomized trial. Comp Ther Med
1998;6:122–6. 61. Gibson RG, Gibson SL, Conway V, et al. Perna canaliculus in the
treatment of arthritis. Practitioner 1980;224L:955–9. 62. Audeval B, Bouchacourt P. Double-blind, placebo-controlled study of
the mussel perna canaliculus (New Zealand green-lipped mussel) in gonarthrosis (arthritis of
the knee). Gazette Med 1986;93:111–5. 63. Brooks PM. Side effects from Seatone. Med J Aust 1980;2:158
[letter]. 64. American Medical Association. Dimethyl sulfoxide. Controversy and
Current Status—1981. JAMA 1982;248:1369–71. 65. Jimenez RA, Willkens RF. Dimethyl sulfoxide: a perspective of its use
in rheumatic diseases. J Lab Clin Med 1982;100:489–500. 66. Eberhardt R, Zwingers T, Hofmann R. DMSO in patients with active
gonarthrosis. A double-blind placebo controlled phase III study. Fortschr Med
1995;113:446–50 [in German]. 67. Jacob SW, Wood DC. Dimethyl sulfoxide (DMSO). Toxicology,
pharmacology, and clinical experience. Am J Surg 114:414–26. 68. Lawrence RM. Methylsulfonylmethane (MSM): a double-blind study of its
use in degenerative arthritis. Int J of Anti-Aging Med 1998;1:50. 69. Akhtar NM, Naseer R, Farooqi AZ, et al. Oral enzyme combination
versus diclofenac in the treatment of osteoarthritis of the knee - a double-blind prospective
randomized study. Clin Rheumatol 2004;23:410–5. 70. Siemandi H. The effect of cis-9-cetyl myristoleate (CMO) and
adjunctive therapy on arthritis and auto-immune disease: a randomized trial. Townsend
Letter for Doctors and Patients 1997;Aug/Sept:58–63. 71. Newnham RE. The role of boron in human nutrition. J Applied
Nutr 1994;46:81–5. 72. Helliwell TR, Kelly SA, Walsh HP, et al. Elemental analysis of
femoral bone from patients with fractured neck of femur or osteoarthrosis. Bone
1996;18:151–7. 73. Travers RL, Rennie GC, Newnham RE. Boron and arthritis: the results
of a double-blind pilot study. J Nutr Med 1990;1:127–32. 74. Altman R, Gray R. Inflammation in osteoarthritis. Clin Rheum
Dis 1985;11:353. 75. Stammers T, Sibbald B, Freeling P. Fish oil in osteoarthritis.
Lancet 1989;ii:503 [letter]. 76. Stammers T, Sibbald B, Freeling P. Efficacy of cod liver oil as an
adjunct to non-steroidal anti-inflammatory drug treatment in the management of osteoarthritis
in general practice. Ann Rheum Dis 1992;51:128–9. 77. Balagot RC, Ehrenpreis S, Kubota K, Greenberg J. Analgesia in mice
and humans by D-phenylalanine: Relation to inhibition of enkephalin degradation and enkephalin
levels. In: Bonica JJ, Liebeskind JC, Albe-Fessard DG, eds., Advances in Pain Research and
Therapy, Vol 5. New York: Raven Press, 1983, 289–93. 78. Budd K. Use of D-phenylalanine, an enkephalinase inhibitor, in the
treatment of intractable pain. In: Bonica JJ, Liebeskind JC, Albe-Fessard DG, eds.,
Advances in Pain Research and Therapy, Vol 5. New York: Raven Press, 1983,
305–8. 79. Walsh NE, Ramamurthy S, Schoenfeld LS, Hoffman J. Analgesic
effectiveness of D-phenylalanine in chronic pain patients. Arch Phys Med Rehabil
1986;67:436–9. 80. Seltzer S, Marcus R, Stoch R. Perspectives in the control of chronic
pain by nutritional manipulation. Pain 1981;11:141–8 [review]. 81. Prudden JF, Balassa LL. The biological activity of bovine cartilage
preparations. Semin Arthritis Rheum 1974;3:287–320. 82. Reijholec V. Long term studies of antiosteoarthritic drugs: an
assessment. Semin Arthritis Rheum 1987;17(2 Suppl 1):35–53. 83. McCarthy GM, McCarty DJ. Effect of topical capsaicin in the therapy
of painful osteoarthritis of the hands J Rheumatol 1992;19:604–7. 84. Altman RD, Aven A, Holmburg CE, et al. Capsaicin cream 0.025% as
monotherapy for osteoarthritis: a double-blind study. Sem Arth Rheum 1994;23(Suppl
3):25–33. 85. Deal CL, Schnitzer TJ, Lipstein E, et al. Treatment of arthritis with
topical capsaicin: a double-blind trial. Clin Ther 1991;13:383–95. 86. Schnitzer T, Morton C, Coker S. Topical capsaicin therapy for
osteoarthritis pain: achieving a maintenance regimen. Sem Arth Rheum 1994;23(Suppl
3):34–40. 87. Schnitzer T, Morton C, Coker S. Topical capsaicin therapy for
osteoarthritis pain: achieving a maintenance regimen. Sem Arth Rheum 1994;23(Suppl
3):34–40. 88. Deal CL. The use of topical capsaicin in managing arthritis pain: a
clinician’s perspective. Sem Arth Rheum 1994;23(Suppl 3):48–52. 89. Mills SY, Jacoby RK, Chacksfield M, Willoughby M. Effect of a
proprietary herbal medicine on the relief of chronic arthritic pain: a double-blind study.
Br J Rheum 1996;35:874–88. 90. Schmid B, Tschirdewahn B, Kàtter I, et al. Analgesic effects of
willow bark extract in osteoarthritis: results of a clinical double-blind trial. Fact
1998;3:186. 91. Randall C, Meethan K, Randall H, Dobbs F. Nettle sting of Urtica
dioica for joint pain—an exploratory study of this complementary therapy. Compl
Ther Med 1999;7:126–31. 92. Randall C, Randall H, Dobbs F, et al. Randomized controlled trial of
nettle sting for treatment of base-of-thumb pain. J R Soc Med
2000;93:305–9. 93. Srivastava KC, Mustafa T. Ginger (Zingiber officinale) in rheumatism
and musculoskeletal disorders. Med Hypotheses 1992;39:342–8. 94. Bliddal H, Rosetzsky A, Schlichting P, et al. A randomized,
placebo-controlled crossover study of ginger extracts and ibuprofen in osteoarthritis.
Osteoarthritis Cartilage 2000;8:9–12. 95. Altman RD, Marcussen KC. Effects of a ginger extract on knee pain in
patients with osteoarthritis. Arthritis Rheum 2001;44:2531–8. 96. Singh BB, Mishra LC, Vinjamury SP, et al. The effectiveness of
Commiphora mukul for osteoarthritis of the knee: an outcomes study. Altern Ther Health
Med 2003;9:74–9. 97. Leeb BF, Schweitzer H, Montag K, Smolen JS. A metaanalysis of
chondroitin sulfate in the treatment of osteoarthritis. J Rheumatol 2000;27:205-11
[review]. 98. McAlindon TE, LaValley MP, Gulin JP, Felson DT. Glucosamine and
chondroitin for treatment of osteoarthritis: a systematic quality assessment and
meta-analysis. JAMA 2000;283:1469-75 review]. 99. Adam M. Osteoarthritis therapy with gelatin preparations: Results of
a clinical study. Therapiewoche 1991;38:2456–61 [in German]. 100. Chantre P, Cappelaere A, Leblan D, et al. Efficacy and tolerance of
Harpagophytum procumbens versus diacerhein in treatment of osteoarthritis.
Phytomedicine 2000;7:177–83. 101. Safayhi H, Mack T, Saieraj J, et al. Boswellic acids: novel,
specific, nonredox inhibitors of 5-lipoxygenase. J Pharmacol Exp Ther
1992;261:1143–6. 102. Kulkarni RR, Patki PS, Jog VP, et al. Treatment of osteoarthritis
with a herbomineral formulation: a double-blind, placebo-controlled, cross-over study. J
Ethnopharmacol 1991;33:91–5. 103. Bingham R, Bellow BA, Bellow JG. Yucca plant saponin in the
management of arthritis. J Appl Nutr 1975;27:45–51. 104. Piscoya J, Rodriguez Z, Bustamante SA, et al. Efficacy and safety of
freeze-dried cat's claw in osteoarthritis of the knee: mechanisms of action of the species
Uncaria guianensis. Inflamm Res 2001;50:442–8. 105. Zeylstra H. Filipendila ulmaria. Br J Phytotherapy
1998;5:8–12. 106. Rask MR. Colchicine use in five hundred patients with disk disease.
J Neurol Orth Surg 1980;1:1–19. 107. Simmons JW, Harris WP, Koulisis CW, et al. Intravenous colchicine
for low back pain: A double blind study. Spine 1990;15:716–7. 108. Gaw AC, Chang LW, Shaw L-C. Efficacy of acupuncture on
osteoarthritic pain. A controlled, double-blind study. N Engl J Med
1975;293:375–8. 109. Takeda W, Wessel J. Acupuncture for the treatment of pain of
osteoarthritic knees. Arthritis Care Res 1994;7:118–22. 110. Thomas M, Eriksson SV, Lundeberg T. A comparative study of diazepam
and acupuncture in patients with osteoarthritis pain: a placebo controlled study. Am J
Chin Med 1991;19:95–100. 111. Christensen BV, Iuhl IU, Vilbek H, et al. Acupuncture treatment of
severe knee osteoarthrosis. A long-term study. Acta Anaesthesiol Scand
1992;36:519–25. 112. Berman BM, Singh BB, Lao L, et al. A randomized trial of acupuncture
as an adjunctive therapy in osteoarthritis of the knee. Rheumatology (Oxford)
1999;38:346–54. 113. Deyle GD, Henderson NE, Matekel RL, et al. Effectiveness of manual
physical therapy and exercise in osteoarthritis of the knee. A randomized, controlled trial.
Ann Intern Med 2000;132:173–81. |